Dougan Brady W sold HUMA

August 18, 2025 · Form 4 insider transaction

Dougan Brady W sold 549,360 shares of Humacyte, Inc. at $1.83 per share, a transaction worth $1.01M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
549,360
Price
$1.83
Total value
$1.01M
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 18, 2025
Filing dateAugust 20, 2025
Shares owned after1,691,685
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for investors to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.; The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.79 to $1.92. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

View the original Form 4 on SEC EDGAR
Dougan Brady W sold HUMA: August 18, 2025 | Insider Trading Screener